News
9d
News-Medical.Net on MSNShingles and RSV vaccines with AS01 adjuvant reduce dementia riskResearchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...
Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.
Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...
A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...
A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in ...
Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results